TY - JOUR
T1 - Metastatic Calcinosis of Gastric Mucosa
AU - Kosuru, Vatsalya
AU - Mohammed, Azeem
AU - Kapoor, Rajan
AU - Jhaveri, Khushali
AU - Medepalli, Vidya
AU - Mulloy, Laura
AU - Padala, Sandeep Anand
N1 - Publisher Copyright:
© 2020 American Federation for Medical Research.
PY - 2020
Y1 - 2020
N2 - Calcinosis cutis refers to the deposition of calcium salts in the cutaneous and subcutaneous tissue and is frequently associated with inflammation. Gastric calcinosis can be classified into metastatic, dystrophic, and idiopathic; metastatic calcinosis is the most common type. In metastatic calcification, calcium salts are deposited in normal soft tissues in the setting of altered metabolism of serum calcium and phosphorus and is a rare and serious complication of chronic renal failure. The important factors contributing to the development of metastatic calcinosis are hypercalcemia, hyperphosphatemia, and an elevated calcium-phosphate product. The most striking feature of this diagnosis is the calcification around the large joints. While it mostly involves dermis of small and medium-sized vessels, it can rarely affect the mucosal layers of the gastrointestinal (GI) tract. Calcinosis presents as a marker for the presence of calcifications in other organs, such as heart or lung, which can be life-threatening. Patients rarely present with clinical symptoms of GI upset, dyspepsia, or epigastric pain that are attributed to calcinosis. If patients present with GI symptoms, infectious causes remain to be higher on the differential. We present a case of incidental finding of gastric mucosal calcinosis during the workup and treatment of dysphagia.
AB - Calcinosis cutis refers to the deposition of calcium salts in the cutaneous and subcutaneous tissue and is frequently associated with inflammation. Gastric calcinosis can be classified into metastatic, dystrophic, and idiopathic; metastatic calcinosis is the most common type. In metastatic calcification, calcium salts are deposited in normal soft tissues in the setting of altered metabolism of serum calcium and phosphorus and is a rare and serious complication of chronic renal failure. The important factors contributing to the development of metastatic calcinosis are hypercalcemia, hyperphosphatemia, and an elevated calcium-phosphate product. The most striking feature of this diagnosis is the calcification around the large joints. While it mostly involves dermis of small and medium-sized vessels, it can rarely affect the mucosal layers of the gastrointestinal (GI) tract. Calcinosis presents as a marker for the presence of calcifications in other organs, such as heart or lung, which can be life-threatening. Patients rarely present with clinical symptoms of GI upset, dyspepsia, or epigastric pain that are attributed to calcinosis. If patients present with GI symptoms, infectious causes remain to be higher on the differential. We present a case of incidental finding of gastric mucosal calcinosis during the workup and treatment of dysphagia.
KW - chronic kidney disease
KW - hypercalcemia
KW - hyperphosphatemia
KW - metastatic calcinosis cutis
KW - metastatic gastric calcinosis
UR - http://www.scopus.com/inward/record.url?scp=85088093279&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088093279&partnerID=8YFLogxK
U2 - 10.1177/2324709620940482
DO - 10.1177/2324709620940482
M3 - Article
C2 - 32677845
AN - SCOPUS:85088093279
SN - 2324-7096
VL - 8
JO - Journal of Investigative Medicine High Impact Case Reports
JF - Journal of Investigative Medicine High Impact Case Reports
ER -